… Congestive heart failure (CHF) represents a pathological state in … heart failure, the diagnostic
and prognostic significance of the natriuretic peptides in CHF, and the therapeutic potential …

… –APJ regulation in the setting of heart failure and consider how attenuated apelin signalling
… will explore the therapeutic potential of targeting the apelin–APJ system in heart failure and, …

… to be efficacious in preclinical models of heart failure. This review highlights roles of HDACs
in the heart and the therapeutic potential of HDAC inhibitors for the treatment of heart failure. …

… They are similarly upregulated in heart failure and counteract neurohormones that
induce vasoconstriction and fluid retention. BNP may be the superior prognosticator for risk …

… placebo-controlled trial of carvedilol in addition to standard heart failure therapy in 2289
patients with moderate to severe heart failure who were clinically euvolaemic and had an EF of <…

… With the combination of heart failure and myocardial infarction in post–myocardial infarction
studies collectively, we can now feel comfortable with the fact that the combination therapy is …

… New therapeutic targets, agents, and strategies are needed to prevent and treat heart
failure (HF) after a decade of failed research efforts to improve long-term patient outcomes, …

… play a pathogenic role in chronic heart failure (HF) by influencing heart contractility, inducing
… Thus, these cytokines could have a therapeutic potential as adjuvants in stem cell therapy. …

… It is well known that the natural history of chronic heart failure (CHF),regardless of age and
… cardiokinetic, diuretic and peripheral vasodilator therapy. Several previous studies, both in …

… be increased in patients with various heart diseases, the elevation in circulatory … heart failure
in patients admitted to the emergency room with symptoms of decompensated heart failure. …